| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.0064 | 0.9 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | -0.0068 | 0.9 |
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | 0.0045 | 0.9 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | -0.0044 | 0.9 |
| mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | 0.0065 | 0.9 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | -0.016 | 0.9 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | 0.0041 | 0.9 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | -0.0037 | 0.9 |